Please use this identifier to cite or link to this item:
標題: Temporal and spatial expression of biologically active human factor VIII in the milk of transgenic mice driven by mammary-specific bovine alpha-lactalbumin regulation sequences
作者: Chen, C.M.
Wang, C.H.
Wu, S.C.
Lin, C.C.
Lin, S.H.
Cheng, W.T.K.
關鍵字: alpha-lactalbumin promoter;hemophilia A;human factor VIII;mammary;gland;transgenic animal;clotting factor-viii;protein-production;skin fibroblasts;coding;region;gene-therapy;gland;sheep;cdna;hemophilia;deletions
Project: Transgenic Research
期刊/報告no:: Transgenic Research, Volume 11, Issue 3, Page(s) 257-268.
Hemophilia A is one of the major inherited bleeding disorders caused by a deficiency or abnormality in coagulation factor VIII (FVIII). Hemophiliacs have been treated with whole plasma or purified FVIII concentrates. The risk of transmitting blood-borne viruses and the cost of highly purified FVIII are the major factors that restrict prophylaxis in hemophilia therapy. One of the challenges created by the biotechnology revolution is the development of methods for the economical production of highly purified proteins in large scales. Recent developments indicate that manipulating milk composition using transgenesis has focused mainly on the mammary gland as a bioreactor to produce pharmaceuticals. In the present study, a hybrid gene containing bovine alpha-lactalbumin and human FVIII cDNA was constructed for microinjection into the pronuclei of newly fertilized mouse eggs. The alphaLA-hFVIII hybrid gene was confirmed to be successfully integrated and stably germ-line transmitted in 12 (seven females/five males) lines. Western-blot analysis of milk samples obtained from eight of the transgenic founders and F1 offspring indicated that the recombinant hFVIII was secreted into the milk of the transgenic mice. The concentrations of rFVIII ranged from 7.0 to 50.2 mug/ml, over 35-200-fold higher than that in normal human plasma. Up to 13.4 U/ml of rFVIII was detected in an assay in which rFVIII restored normal clotting activity to FVIII-deficient human plasma.
ISSN: 0962-8819
DOI: 10.1023/a:1015651302674
Appears in Collections:生命科學系所

Show full item record

Google ScholarTM




Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.